Member Info for Heimdal

http://hk.eastmoney.com/a/202102091808773911.html

https://us.acrofan.com/detail.php?number=419191

Yeah, such is life Bignose - just roll with the punches. Anyway, strong share price support today which is very positive. I had expected the sp to drift down towards 19.4c to close the gap. The share market is a complex and unpredictable beast. Interactive Brokers still in the market today with yet another 3,000,000 BID order at 20.8c (which was not filled). Strong finish. We might well be heading to 25c soon. Happy days! Heimdal

Yes, interesting trading today. Interactive Brokers finally moved their unfilled 3.6m BID up from 19c to 21c and as soon as it was filled the sp drifted lower lol. We are basically in the hands of pip traders and I guess we will probably drift lower to close the 19.4 - 20c gap. Profit Warning can not be far away but should not have much affect on sp. Lots of news to look forward to on the short to medium track but I had expected a somewhat harder impact from the China announcement given the scale of the market. Heimdal

https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0209/2021020900345.pdf

Wow! :-)

The share price has been drifting sideways for weeks now with a (few very short spikes). Maybe manipulated to keep it in a very tight trading range?? Today we started at 19.9c but was quickly sold down to 19.3c with a small order. The same happened on close so we ended at 19.3c. Interactive Brokers are still active on the BID side, first with a 3.8m order at 19c (not filled) and after lunch it was raised to 19.4c, but as soon as it was hit with a 970k sell the rest of the order was lowered to 19.2c - playing silly b_ggers?. BID depth at or above 19c was quite solid all day around 5m. Last time I have seen this tight trading range for weeks and weeks was just before the UK launch in 2016. Next week will be a short one given the CNY, only 1/2 day trading on Thursday and no trading on Friday and next Monday. May the year of the golden Ox bring you fortune and good health. Heimdal

Looking at the chart, the 575 share price did indeed bounce off SMA (50), and the slow STC and Ultimate Oscillator indicators suggest we are now set for the next leg up. HK Bulls also back onboard today. Heimdal

3,800,000 BUY order from Interactive Brokers sitting in the BID queue at 19c on open. They probably have to move higher in order to get it filled. lol

US based Interactive Brokers have been busy on the BID side with 3,000,000 orders during the last few days. BID orders placed from 18.9c to 19.2c. As soon as one Bid order is filled a new 3,000,000 bid order pops up. Interesting times. Heimdal

Good morning Professor, good to have you back onboard. My main worry is the overheating US market. The current S&P500 10-year P/E ratio is now a staggering 33.91. This is 71% above the modern-era market average of 19.6, putting the current P/E over 1 standard deviation above the modern-era average. Such high P/E ratio is clearly unsustainable and a correction might well be underway now, dragging the rest of the world markets down as well. In the last couple of weeks we have seen a dramatic increase in the short selling ratio in many stocks on the HKSE which is a cause for concern. It is not possible to short 575 as the MCap is too low at the moment. This trading week will be most interesting with the revolutionary Reddit army and all. On the long track this should only be a bump in the road for the 575 sp. Heimdal

Good observation Escovido but not back in February-March when the global market tanked.
Markets are overheating (not least in the US) and a 10-20% correction might well be due. If so
we might find support around the 15c level. Time will tell. On the long track I am sure we will do well.

KGI Asia and Fulbright pushing the sp higher at the moment, P&D before a correction? Remember the spike end of January last year where we went from 10c to 20c within two days on high volume?

The Hang Seng Index has risen +3,000 points (10%) during the past one month.Such a rapid rise is unsustainable, as such I expect we must be very close to a correction as the market is overheating. I expect we will find support around the 15c level before we move up again. Your thoughts? Heimdal

News from DLI: https://www.bio-itworld.com/news/2021/01/21/deep-longevity-building-an-arsenal-of-aging-clocks

During the last two months Regent Pacific released six Operations Updates and I expect the frequent updates will continue which will drive the share price upwards:

?Final profit warning (Feb)
Confirmation of Macao launch (March)
China CTA news and invoice for HK$25m (March)
Confirmation of Taiwan launch (April)
Confirmation of China clinical trial start (April-May)
USA marketing study news (May)
Potential USA partner ahead of Phase III (would have a major impact on sp)
Confirmation of USA Phase II study submission (first half of 2021)
News on Japan progress
News on EU OTC roll out progress
Potential news on LATAM, India and Middle East commercial strategic partners
I also expect frequent updates on DLI developments. It is now six weeks since we closed the deal and as such an update is overdue.

All in all a fair bit of news to look forward to.

Heimdal

I think there is a good chance PS will be snapped up within the next two years by one of the big players such as Pfizer for ?US500m. Current Mcap is just US$50m so a share price of HK$2 might be achiveable? Completion of phase 2 in USA significantly derisk commerzialisation. Heimdal

Dougie, longer term HK$1-2. I think next target will be 22c, then 25c, 30c and about 36c by end of 2021. Heimdal

Thanks Bignose, always appreciate your comments as a major holder. The 2016 spike was a very interesting event leading to a fair bit of speculation. WRT listing rule 13.24, this is clearly something we need to keep an eye on. Webb-Site Reports is a good source of information, a bit quiet recently though generated by David's health issues.

575 BUY depth looking quite solid with about 5m in total from 19 - 20c on close. Looks like the punters are back after the successful inauguration of Joe Biden. Happy with the close above 20c. The share price can move very quickly, remember end of January last year where the share price doubled (from intraday low of 10c to intraday highh of 20c) in two days on no news..

Heimdal

David Webb's Webb-Site Reports are always worth reading. In NOV 2018 he mentioned 41 endangered stocks
https://webb-site.com/articles/patients.asp . Just checking a few of them this morning and they are still trading which is clearly positive.

Another in depth article about the new listing rules here - https://webb-site.com/articles/adverseopinion.asp

Squeeze-outs

For some controlling shareholders, the prospect of a mandatory suspension and delisting would be music to their ears. It would put them in a position to buy out the minority shareholders, now deprived of a market for their shares and the disclosures required by the Listing Rules, at a knock-down price. The controller would avoid the normal delisting approvals needed under Rule 2.2 of the Takeovers Code, even if the company is still regarded as a "public company" by the SFC.

HKEX's conflict of interest

Finally, let's not ignore the financial interest that HKEX has in these proposals. It makes the vast majority of its monopolistic profit on the trading, clearing and settlement fees of larger listed companies in HK and the derivatives linked to them. From HKEX's perspective, small troubled companies are loss-makers, because they consume a disproportionate amount of regulatory staff-hours relative to the overall fees they generate. Ranked by size, on the Main Board at the end of September, 344 companies (18% of 1881) accounted for 90% of the market value. Including GEM and Secondary listings, 362 companies (16% of 2268) accounted for 90% of the market value. Their proportion of turnover and transaction fees is even greater than 90% because the market-value figure includes many large H-share issuers, most of which have nearly 100% free float (the mainland A-shares not being counted towards market value).

The regulatory staff-hours consumed by small companies in financial or other difficulties can be dispensed with if they are quickly delisted rather than rehabilitated, thereby boosting profits for HKEX and its shareholders, including the Government. Put simply, it is cheaper to kill the patients than to cure them.

BTW: BUY depth looking good this morning and we are back at 20c, I really hope we can hold the line and move up from here.

Heimdal

You might be right Keith. However I did have high hopes for a re-rating (or at least a massive spike like the 2016 launch in England) on the back of the HK launch news. Maybe the headline wording was wrong, market update.. With 2,538 listed companies and abundant announcements every day you need a more hard hitting headline to grab the punters attention.